The Journal of Clinical Psychiatryis the official journal of the American Society of Clinical Psychopharmacology (ASCP). Each month, the ASCP contributes "ASCP Corner" to the Journal. The Corner contains short evidence-based discussions on clinical psychopharmacology and periodically contains news of the Society and announcements of Society meetings and activities.
Available ASCP Corners
2011
Stepping Back to Step Forward: Lessons From the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)
Assessing the Adequacy of Past Antidepressant Trials: A Clinician’s Guide to the Antidepressant Treatment Response Questionnaire
Rediscovering Adverse Anticholinergic Effects
Number Needed to Treat: What It Is and What It Isn’t, and Why Every Clinician Should Know How to Calculate It
Omega-3 Fatty Acids and Depression: From Cellular Mechanisms to Clinical Care
2010
New Antipsychotic Drugs: How Do Their Receptor-Binding Profiles Compare?
Bereavement, Complicated Grief, and DSM, Part 2: Complicated Grief
Bereavement, Complicated Grief, and DSM, Part 1: Depression
Therapeutic Drug Monitoring in Pregnant and Postpartum Women: Recommendations for SSRIs, Lamotrigine, and Lithium
Transcranial Magnetic Stimulation for Medication-Resistant Depression
How to Efficiently Maintain Your Own Electronic Resource Library
2009
Reconceptualizing Medication Management: Implications for Training and Clinical Practice
Do Glutamatergic Agents Represent a New Class of Antidepressant Drugs? Part 2
Do Glutamatergic Agents Represent a New Class of Antidepressant Drugs? Part 1
Genetic Studies of Drug Response and Side Effects in the STAR*D Study, Part 2
Genetic Studies of Drug Response and Side Effects in the STAR*D Study, Part 1
Suicide Risk and Psychopharmacology: Assessment and Management of Acute and Chronic Risk Factors
[PDF]
Adding Lithium or Anticonvulsants to Antipsychotics for the Treatment of Schizophrenia: Useful Strategy or Exercise in Futility?
[PDF]
Second-Generation Antipsychotic-Associated Diabetes Mellitus and Diabetic Ketoacidosis: Mechanisms, Predictors, and Screening Need
[PDF]
All Antipsychotics Are Equal, but Some Are More Equal Than Others
[PDF]
Breast Feeding and Antidepressants: Clinical Dilemmas and Expert Perspectives.
[PDF]
Why Aren't MAOIs Used More Often?
[PDF]
2008
Is the Problem of a High Placebo Response Unique to Antidepressant Trials?
[PDF]
Qualifications for Recertification: An Important but Evolving Set of Standards.
[PDF]
Commentary.
[PDF]
The Search for Knowledge: Developing the American Psychiatric Association's Practice Guideline for Major Depressive Disorder.
[PDF]
Are Nutritional Supplements Ready for Prime Time?
[PDF]
Are Antidepressants Effective? What’s a Clinician to Think?
[PDF]
Antipsychotic Polypharmacy, Part 2: Why Use 2 Antipsychotics When 1 Is Not Good Enough?
[PDF]
Antipsychotic Polypharmacy, Part 1: Shotgun Approach or Targeted Cotreatment?
[PDF]
What Constitutes Evidence-Based Pharmacotherapy for Bipolar Disorder? Part 2: Complex Presentations and Clinical Context
[PDF]
Balancing Risks: Dosing Strategies for Antidepressants Near the End of Pregnancy
[PDF]
State of the Society.
[PDF]
[top]
2007
What Constitutes Evidence-Based Pharmacotherapy for Bipolar Disorder? Part 1: First-Line Treatments.
[PDF]
Teaching and Practicing Psychopharmacology
[PDF]
Clinical Psychopharmacology of Pediatric Mood Stabilizer and Antipsychotic Treatment, Part 2: Methodological Considerations
Worried Sick: Antidepressants, Stress, and Inflammation
[PDF]
Clinical Psychopharmacology of Pediatric Mood Stabilizer and Antipsychotic Treatment, Part 2: Methodological Considerations
[PDF]
Clinical Psychopharmacology of Pediatric Mood Stabilizer and Antipsychotic Treatment, Part 1: Challenges and Developments
[PDF]
Dual Dependency on Cocaine and Alcohol in Opiate Addicts: Treatment Options
[PDF]
Pharmacoepidemiology: Recent Findings and Challenges for Child and Adolescent Psychopharmacology
[PDF]
Psychopharmacology in the Emergency Room
[PDF]
Psychopharmacologic Treatment Response of HIV-Infected Patients to Antipsychotic Medications
[PDF]
Choice of Antipsychotic in HIV-Infected Patients
[PDF]
The Psychopharmacology of Violence With Emphasis on Schizophrenia, Part 2: Long Term Treatement
[PDF]
The Psychopharmacology of Violence With Emphasis on Schizophrenia, Part 1: Acute Treatement
[PDF]
[top]
2006
Primary Care Pitfalls for the Psychiatrist Psychopharmacologist
[PDF]
Measurement-Based Psychiatry: Definitions of Response, Remission, Stability, and Relapse in Schizophrenia
[PDF]
Combining Pharmacotherapy With Psychotherapeutic Management: Guidelines for Integration
[PDF]
Buprenorphine: Reflections of an Addictions Psychiatrist
[PDF]
FDA Post-Marketing Safety Decisions
[PDF]
ASCP Administers 10th Certification Exam
[PDF]
Female Sexual Dysfunctions: What Controversy?
[PDF]
Commentary on the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE)
[PDF]
Novel Transdermal Delivery Formulation of the Monoamine Oxidase Inhibitor Selegiline Nearing Release for Treatment of Depression
[PDF]
Use of Atypical Antipsychotics: Observations From Clinical Practice
[PDF]
Complex Chemical Concoctions
[PDF]
Real-Life Switching Strategies With Second-Generation Antipsychotics
[PDF]
[top]
2005
Real-Life Dosing With Second-Generation Antipsychotics
[PDF]
Sexual Function and Dysfunction During Treatment With Psychotropic Medications
[PDF]
Metabolic Side Effects of Second-Generation Antipsychotics in Children and Adolescents: A Different Story?
[PDF]
Gender Differences in Clinical Psychopharmacology
[PDF]
Increased Risk of Cerebrovascular Adverse Events and Death in Elderly Demented Patients Treated With Atypical Antipsychotics: What’s a Clinician to Do?
[PDF]
Challenges and Opportunities in Teaching Psychopharmacology During Residency Training
[PDF]
Cultural Competence in Clinical Psychopharmacology
[PDF]
Reading Reports of Clinical Trial Results
[PDF]
From the President
[PDF]
[top]



Keyword Search